KWBT logo

Kiwa Bio-Tech Products Group Corporation (KWBT)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Kiwa Bio-Tech Products Group Corporation (KWBT) with AI Score 51/100 (Hold). Kiwa Bio-Tech Products Group Corporation develops, manufactures, and distributes bio-technological products for the agricultural market, primarily in China. Market cap: 0, Sector: Basic materials.

Last analyzed: Mar 17, 2026
Kiwa Bio-Tech Products Group Corporation develops, manufactures, and distributes bio-technological products for the agricultural market, primarily in China. The company focuses on bio-fertilizers to improve crop yields and soil health.
51/100 AI Score

Kiwa Bio-Tech Products Group Corporation (KWBT) Materials & Commodity Exposure

CEOZiqi Wang
Employees16
HeadquartersYangling, CN
IPO Year2002

Kiwa Bio-Tech Products Group Corporation focuses on developing and distributing bio-fertilizers in the Chinese agricultural market, leveraging strategic partnerships and proprietary technology to offer sustainable solutions for crop yield enhancement and soil health, operating within a competitive landscape of both domestic and international players.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 17, 2026

Investment Thesis

Kiwa Bio-Tech Products Group Corporation presents a focused play on the growing demand for bio-fertilizers in China. The company's strategic partnerships with research institutions and its range of bio-fertilizer products position it to capitalize on the increasing adoption of sustainable agricultural practices. However, the company's negative profit margin of -16.6% and lack of dividend payments raise concerns about its financial stability. The high beta of 2.91 suggests significant volatility. Future growth hinges on successful product commercialization, expansion of distribution networks, and effective management of operational costs. Investors should closely monitor the company's ability to achieve profitability and generate positive cash flow.

Based on FMP financials and quantitative analysis

Key Highlights

  • Kiwa Bio-Tech operates in the agricultural inputs sector, focusing on bio-fertilizers.
  • The company's products include bacillus species-based biological organic, compound microbial, bio-water soluble, and microbial inoculum fertilizers.
  • Kiwa Bio-Tech has strategic cooperation agreements with several agricultural research institutions in China.
  • The company's gross margin is 23.3%.
  • The company's profit margin is -16.6%.

Competitors & Peers

Strengths

  • Proprietary bio-fertilizer technology
  • Strategic partnerships with research institutions
  • Established presence in the Chinese market
  • Focus on sustainable agriculture

Weaknesses

  • Negative profit margin
  • Limited financial resources
  • Dependence on the Chinese market
  • Small number of employees

Catalysts

  • Ongoing: Increasing demand for bio-fertilizers in China due to environmental concerns and government support.
  • Ongoing: Strategic partnerships with research institutions to develop innovative products.
  • Upcoming: Potential expansion into new geographic markets within China.
  • Upcoming: Development and launch of new bio-fertilizer products targeting specific crops.
  • Ongoing: Government subsidies and incentives for sustainable agriculture practices.

Risks

  • Ongoing: Competition from larger agricultural companies with greater resources.
  • Potential: Fluctuations in raw material prices affecting production costs.
  • Potential: Changes in government regulations impacting the bio-fertilizer industry.
  • Potential: Economic slowdown in China reducing demand for agricultural products.
  • Ongoing: Limited financial resources and negative profit margin.

Growth Opportunities

  • Expansion of Product Line: Kiwa Bio-Tech can expand its product line to include a wider range of bio-fertilizers and related agricultural products. This could involve developing new formulations, targeting specific crops, or addressing specific soil conditions. The market for specialized bio-fertilizers is growing, as farmers seek tailored solutions for their needs. This expansion could increase revenue streams and market share, with a potential market size of $5 billion by 2030.
  • Geographic Expansion within China: Kiwa Bio-Tech can expand its geographic reach within China, targeting regions with high agricultural activity and a growing demand for bio-fertilizers. This could involve establishing new distribution partnerships, opening regional offices, or participating in agricultural trade shows. The Chinese agricultural market is vast and diverse, offering significant opportunities for growth. This expansion could increase sales volume and brand awareness, with a timeline of 3-5 years.
  • Strategic Partnerships and Acquisitions: Kiwa Bio-Tech can pursue strategic partnerships and acquisitions to enhance its technological capabilities, expand its product portfolio, or gain access to new markets. This could involve collaborating with research institutions, acquiring smaller bio-fertilizer companies, or partnering with agricultural distributors. Strategic alliances can accelerate growth and create synergies, with ongoing opportunities.
  • Increased Focus on Research and Development: Kiwa Bio-Tech can increase its investment in research and development to develop innovative bio-fertilizer products and improve existing formulations. This could involve conducting field trials, collaborating with universities, or hiring experienced scientists. Innovation is crucial for maintaining a competitive edge in the bio-fertilizer market, with a continuous timeline.
  • Government Support and Subsidies: Kiwa Bio-Tech can leverage government support and subsidies for the development and adoption of bio-fertilizers. The Chinese government is actively promoting sustainable agriculture and providing financial incentives for farmers to use environmentally friendly products. This support can reduce costs and increase demand for Kiwa Bio-Tech's products, with ongoing opportunities.

Opportunities

  • Expanding product line
  • Geographic expansion within China
  • Increasing demand for bio-fertilizers
  • Government support for sustainable agriculture

Threats

  • Competition from larger agricultural companies
  • Fluctuations in raw material prices
  • Changes in government regulations
  • Economic slowdown in China

Competitive Advantages

  • Proprietary bio-fertilizer formulations
  • Strategic partnerships with research institutions
  • Established distribution network in China
  • Brand recognition in the Chinese agricultural market

About KWBT

Kiwa Bio-Tech Products Group Corporation, established in 2002 and headquartered in Yangling, China, is dedicated to the development, manufacturing, and distribution of bio-technological products tailored for the agricultural sector. The company's core offerings include a range of bio-fertilizers, encompassing bacillus species-based biological organic fertilizers, compound microbial fertilizers, bio-water soluble fertilizers, and microbial inoculum fertilizers. These products are designed to enhance crop yields, improve soil health, and promote sustainable agricultural practices. Kiwa Bio-Tech has strategically aligned itself with key institutions such as the Beijing Zhongpin Agricultural Science and Technology Development Center, the China Academy of Agricultural Science's Institute of Agricultural Resources & Regional Planning, and the Institute of Agricultural Economy & Development, as well as Kiwa Bio-Tech (Yangling) Co. Ltd. These collaborations facilitate research, development, and market access within the Chinese agricultural landscape. The company's focus on bio-fertilizers addresses the growing demand for environmentally friendly agricultural solutions in China, driven by increasing awareness of soil degradation and the need for sustainable farming practices.

What They Do

  • Develops bio-technological products for the agricultural market.
  • Manufactures bio-fertilizers.
  • Markets bio-fertilizers.
  • Distributes bio-fertilizers.
  • Offers bacillus species-based biological organic fertilizers.
  • Offers compound microbial fertilizers.
  • Offers bio-water soluble fertilizers.
  • Offers microbial inoculum fertilizers.

Business Model

  • Develops and manufactures bio-fertilizers.
  • Sells bio-fertilizers to distributors and farmers.
  • Generates revenue through product sales.
  • Forms strategic partnerships for research and development.

Industry Context

Kiwa Bio-Tech operates within the agricultural inputs industry, specifically focusing on the bio-fertilizer segment. The Chinese agricultural sector is undergoing a shift towards sustainable practices, driven by government regulations and increasing awareness of environmental concerns. The market for bio-fertilizers is growing, as farmers seek alternatives to traditional chemical fertilizers. Kiwa Bio-Tech competes with both domestic and international players in this space. The industry is characterized by technological innovation, product differentiation, and the need for strong distribution networks to reach farmers across China.

Key Customers

  • Farmers in China
  • Agricultural distributors
  • Agricultural cooperatives
  • Large-scale agricultural operations
AI Confidence: 69% Updated: Mar 17, 2026

Financials

Chart & Info

Kiwa Bio-Tech Products Group Corporation (KWBT) stock price: Price data unavailable

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for KWBT.

Price Targets

Wall Street price target analysis for KWBT.

MoonshotScore

51/100

What does this score mean?

The MoonshotScore rates KWBT's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Ziqi Wang

CEO

Ziqi Wang serves as the CEO of Kiwa Bio-Tech Products Group Corporation. Information regarding Ziqi Wang's detailed career history, education, and previous roles is not available in the provided data. Further research would be needed to provide a comprehensive background.

Track Record: Due to limited information, Ziqi Wang's key achievements, strategic decisions, and company milestones under their leadership cannot be accurately assessed. Additional data is required to evaluate their track record effectively.

KWBT OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Kiwa Bio-Tech Products Group Corporation may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited regulatory oversight and potentially higher risks compared to companies listed on major exchanges or higher OTC tiers. This tier often includes companies with distressed financials, early-stage ventures, or those that choose not to comply with stricter listing standards.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Trading volume for OTC Other stocks like KWBT is typically very low, resulting in wide bid-ask spreads. This can make it difficult to buy or sell shares without significantly impacting the price. Investors may experience challenges in executing large trades or exiting their positions quickly due to the limited liquidity.
OTC Risk Factors:
  • Limited financial disclosure
  • Low trading volume and liquidity
  • Potential for price manipulation
  • Higher risk of fraud or mismanagement
  • Lack of regulatory oversight
Due Diligence Checklist:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's legal and regulatory compliance.
  • Check for any red flags or warning signs.
  • Consult with a financial advisor.
  • Understand the risks associated with investing in OTC stocks.
Legitimacy Signals:
  • Strategic partnerships with reputable organizations
  • Positive media coverage or industry recognition
  • Experienced management team
  • Clear business plan and growth strategy
  • Audited financial statements (if available)

Common Questions About KWBT

What does Kiwa Bio-Tech Products Group Corporation do?

Kiwa Bio-Tech Products Group Corporation develops, manufactures, and distributes a range of bio-fertilizers for the agricultural market, primarily in China. These bio-fertilizers are designed to enhance crop yields, improve soil health, and promote sustainable agricultural practices. The company leverages strategic partnerships with research institutions to develop and commercialize its products, targeting the growing demand for environmentally friendly agricultural solutions.

What do analysts say about KWBT stock?

As of 2026-03-17, there is no available analyst coverage or consensus on Kiwa Bio-Tech Products Group Corporation (KWBT). The company's market capitalization is $0.00B, and it trades on the OTC market. Investors should conduct their own due diligence and consider the risks associated with investing in OTC stocks, including limited liquidity and financial disclosure.

What are the main risks for KWBT?

Kiwa Bio-Tech Products Group Corporation faces several risks, including competition from larger agricultural companies, fluctuations in raw material prices, and changes in government regulations. The company's negative profit margin and limited financial resources also pose significant challenges. Additionally, as an OTC-listed company, KWBT is subject to higher risks associated with limited liquidity, financial disclosure, and regulatory oversight.

What are the key factors to evaluate for KWBT?

Kiwa Bio-Tech Products Group Corporation (KWBT) currently holds an AI score of 51/100, indicating moderate score. Key strength: Proprietary bio-fertilizer technology. Primary risk to monitor: Ongoing: Competition from larger agricultural companies with greater resources.. This is not financial advice.

How frequently does KWBT data refresh on this page?

KWBT prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven KWBT's recent stock price performance?

Recent price movement in Kiwa Bio-Tech Products Group Corporation (KWBT) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Proprietary bio-fertilizer technology. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider KWBT overvalued or undervalued right now?

Determining whether Kiwa Bio-Tech Products Group Corporation (KWBT) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying KWBT?

Before investing in Kiwa Bio-Tech Products Group Corporation (KWBT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Limited information available on the company's financials and operations.
  • OTC market carries inherent risks due to lower regulation and liquidity.
Data Sources

Popular Stocks